The goal of Ménière's disease management is to control vertigo while minimizing adverse effects. Although intratympanic gentamicin(ITG) is effective, its vestibulotoxic and cochleotoxic potential remains a concern. OBJECTIVE: To compare ITG and endolymphatic duct blockage(EDB) in terms of vertigo control, hearing preservation, and vestibular function.
✦ The floor
Discussion
Signed responses from readers of the wire.
Results comparing endolymphatic duct blockage to intratympanic gentamicin for refractory Ménière's disease are directly relevant to surgical and medical decision-making; audiologists managing these patients should review the full data to understand hearing and vertigo outcomes for each approach.
For the significant minority of Ménière's patients who fail medical therapy, head-to-head evidence comparing a surgical option with intratympanic gentamicin is scarce, making this study directly practice-informing.
- 01Head-to-head comparison of endolymphatic duct blockage (surgery) vs. intratympanic gentamicin (antibiotic injection) in refractory Ménière's disease.
- 02Primary focus is vertigo control rate and adverse effects, including potential hearing loss from gentamicin (ototoxicity).
- 03Both interventions target patients who have not responded to conventional treatments.
- 04Intratympanic gentamicin carries a known risk of ototoxicity (medication-related hearing damage); the study quantifies this risk.
- 05Results may help clinicians and patients choose between a surgical and a pharmacological second-line approach.
Endolymphatic duct blockage and intratympanic gentamicin differ in vertigo control rates in refractory Ménière's disease.
studyunclearIntratympanic gentamicin carries a risk of ototoxicity (hearing damage) as an adverse effect in Ménière's disease treatment.
studysupported- PMID
- 43013507
- DOI
- 10.1080/00016489.2026.2750761.
- Journal
- Acta Oto-Laryngologica
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients with refractory Ménière's disease unresponsive to conventional treatment
- Intervention
- Endolymphatic duct blockage (surgical procedure)
- Comparator
- Intratympanic gentamicin injection
Primary outcomes
Vertigo control rate; Adverse effects including ototoxicity